연구성과로 돌아가기
2020 연구성과별 연구자 정보 (65 / 2428)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Kang, Won Ki | Kang, WK | 9 | Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematol Oncol,Sch Med, Seoul, South Korea | nboku@ncc.go.jp; | |||||
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Yeh, Kun-Huei | Yeh, KH | 10 | Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan | HGD-3316-2022 | Yeh, Kun-Huei | 0000-0002-7306-174X | YEH, Kun-Huei | nboku@ncc.go.jp; | |
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Yeh, Kun-Huei | Yeh, KH | 10 | Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Oncol, Coll Med, Taipei, Taiwan | HGD-3316-2022 | Yeh, Kun-Huei | 0000-0002-7306-174X | YEH, Kun-Huei | nboku@ncc.go.jp; | |
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Yoshikawa, Takaki | Yoshikawa, T | 11 | Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan | Y-1580-2019 | Yoshikawa, Takaki | nboku@ncc.go.jp; | |||
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Yoshikawa, Takaki | Yoshikawa, T | 11 | Natl Canc Ctr, Dept Gastr Surg, Tokyo, Japan | Y-1580-2019 | Yoshikawa, Takaki | nboku@ncc.go.jp; | |||
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Oh, Sang Cheul | Oh, SC | 12 | Korea Univ, Coll Med, Dept Internal Med, Div Hematol & Oncol, Seoul, South Korea | nboku@ncc.go.jp; | |||||
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Bai, Li-Yuan | Bai, LY | 13 | China Med Univ, China Med Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Taichung, Taiwan | nboku@ncc.go.jp; | |||||
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Tamura, Takao | Tamura, T | 14 | Kindai Univ, Fac Med, Dept Med Oncol, Osakasayama, Japan | nboku@ncc.go.jp; | |||||
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Tamura, Takao | Tamura, T | 14 | Kindai Univ, Dept Med Oncol, Nara Hosp, Ikoma, Japan | nboku@ncc.go.jp; | |||||
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Lee, Keun-Wook | Lee, KW | 15 | Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Hematol & Oncol,Coll Med, Seongnam, South Korea | nboku@ncc.go.jp; | |||||
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Hamamoto, Yasuo | Hamamoto, Y | 16 | Keio Univ, Keio Canc Ctr, Sch Med, Tokyo, Japan | AAA-9941-2022 | Hamamoto, Yasuo | 0000-0002-5737-122X | Hamamoto, Yasuo | nboku@ncc.go.jp; | |
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Kim, Jong Gwang | Kim, JG | 17 | Kyungpook Natl Univ, Sch Med, Daegu, South Korea | nboku@ncc.go.jp; | |||||
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Chin, Keisho | Chin, K | 18 | Japanese Fdn Canc Res, Dept Gastroenterol, Canc Inst Hosp, Tokyo, Japan | nboku@ncc.go.jp; | |||||
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Oh, Do-Youn | Oh, DY | 19 | Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea | nboku@ncc.go.jp; | |||||
| A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data | Minashi, Keiko | Minashi, K | 20 | Chiba Canc Ctr, Clin Trial Promot Dept, Chiba, Japan | nboku@ncc.go.jp; |
페이지 이동: